| Date Filed | Type | Description |
| 09/28/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/28/2023 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Bought 5,703 shares
@ $7.65, valued at
$43.6k
Bought 13,687 shares
@ $8.3, valued at
$113.6k
Bought 5,419 shares
@ $9.52, valued at
$51.6k
Bought 37,911 shares
@ $11.05, valued at
$418.9k
Bought 77,837 shares
@ $11.81, valued at
$919.3k
Bought 42,838 shares
@ $12.84, valued at
$550k
Bought 30,511 shares
@ $13.92, valued at
$424.7k
Bought 3,326 shares
@ $14.61, valued at
$48.6k
Bought 27,769 shares
@ $16, valued at
$444.3k
Bought 75,477 shares
@ $17.28, valued at
$1.3M
Bought 52,691 shares
@ $18.24, valued at
$961.1k
|
|
| 08/24/2023 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend] |
| 08/15/2023 |
SC 13D/A
| PERCEPTIVE ADVISORS LLC reports a 22.1% stake in Soleno Therapeutics, Inc. |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/12/2023 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on MeiraGTx Holdings plc|
Txns:
| Granted 20,000 options to buy
@ $8.04, valued at
$160.8k
Granted 20,000 options to buy
@ $0 |
|
| 06/08/2023 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 9,650 options to buy
@ $6.37, valued at
$61.5k
|
|
| 06/06/2023 |
SC 13D/A
| PERCEPTIVE ADVISORS LLC reports a 27% stake in Soleno Thereputics, Inc. |
| 06/06/2023 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Bought 64,630 shares
@ $5.93, valued at
$383.3k
Bought 78,468 shares
@ $5.98, valued at
$469.2k
Bought 200 shares
@ $5.93, valued at
$1.2k
|
|
| 06/01/2023 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Bought 17,500 shares
@ $5.34, valued at
$93.5k
Bought 10,000 shares
@ $5.28, valued at
$52.8k
Bought 7,500 shares
@ $5.59, valued at
$41.9k
|
|
| 05/26/2023 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Bought 25,000 shares
@ $5.48, valued at
$137k
Bought 37,500 shares
@ $5.18, valued at
$194.3k
Bought 22,500 shares
@ $5.27, valued at
$118.6k
|
|
| 05/25/2023 |
SC 13D/A
| PERCEPTIVE ADVISORS LLC reports a 23.8% stake in Soleno Thereputics, Inc. |
| 05/23/2023 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Bought 25,200 shares
@ $4.62, valued at
$116.4k
Bought 27,300 shares
@ $5.12, valued at
$139.8k
Bought 27,500 shares
@ $5.45, valued at
$149.9k
|
|
| 05/18/2023 |
SC 13D
| PERCEPTIVE ADVISORS LLC reports a 22.8% stake in Soleno Thereputics, Inc. |
| 05/18/2023 |
3
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 3 on SOLENO THERAPEUTICS INC |
| 05/16/2023 |
SC 13D/A
| PERCEPTIVE ADVISORS LLC reports a 19.1% stake in MeiraGTx Holdings plc |
| 05/15/2023 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on MeiraGTx Holdings plc|
Txns:
| Bought 4,347,826 shares
@ $5.75, valued at
$25M
|
|
| 05/04/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/01/2023 |
4
| Perceptive Credit Advisors, LLC (Former 10% Owner) has filed a Form 4 on CHEMBIO DIAGNOSTICS, INC.|
Txns:
| Unknown transaction of 5,162,782 shares
@ $0.45, valued at
$2.3M
|
|
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/21/2023 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2023 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 8.9% stake in Bellerophon Therapeutics, Inc. |
| 03/07/2023 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 6.5% stake in Reata Pharmaceuticals, Inc. |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 0% stake in Neptune Wellness Solutions Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 0% stake in Research Alliance Corp. II |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 9.3% stake in Rain Oncology Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 12.3% stake in Verrica Pharmaceuticals Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 7.6% stake in Inhibrx, Inc. |
|